ABCB1
|
CC
|
CT+TT
|
U test
|
P-value
|
Sig.
|
---|
2nd month
| | | | | |
Dose
|
Median (IQR)
|
0.05(0.04–0.08)
|
0.08(0.04–0.1)
|
−0.812
|
0.417
|
NS
|
Range
|
0.02–0.1
|
0.03–0.1
|
Trough level
|
Median (IQR)
|
6.65(5.9–8.1)
|
6.05(5.1–9.85)
|
−0.222
|
0.824
|
NS
|
Range
|
2.2–10.6
|
3.8–14.6
|
C/D
|
Median (IQR)
|
108(82.5–167)
|
86(54.5–184.5)
|
−0.355
|
0.722
|
NS
|
Range
|
49–213
|
47–486
|
3rd month
| | | | | |
Dose
|
Median (IQR)
|
0.05(0.03–0.06)
|
0.08(0.05–0.1)
|
−1.878
|
0.060
|
NS
|
Range
|
0.01–0.07
|
0.02–0.1
|
Trough level
|
Median (IQR)
|
5.4(2.1–8.2)
|
5.35(4.5–6.95)
|
−0.089
|
0.929
|
NS
|
Range
|
1.4–9.1
|
3.2–7.4
|
C/D
|
Median (IQR)
|
142.5(71–150)
|
90.5(59.5–119.75)
|
−1.422
|
0.155
|
NS
|
Range
|
47–225
|
32–205
|
- P-value >0.05, non-significant (NS); P-value <0.05, significant (S); P-value< 0.01, highly significant (HS)